Our Services
Medical Information
Helpful Resources
Published on: 10/26/2026
Extended-release nifedipine (Procardia XL) most often causes swelling in the ankles or feet, headache, dizziness, flushing, fatigue, nausea, and constipation, with many of these easing over the first few weeks. Less common but important effects include low blood pressure, rapid heartbeat, gum overgrowth, and worsening chest pain, which can signal a dose that is too high or needs slower adjustment. Timing, dosage, grapefruit juice, other blood pressure drugs, and stopping the medication abruptly can all change how side effects show up, so there are several factors to consider before assuming a symptom is harmless. See below to understand which reactions are expected, which warrant a call to your prescriber, and which need urgent care.
If you are unsure whether your swelling, headaches, or heart palpitations are a normal adjustment or a warning sign, a free, instant, online symptom check can help you sort likely causes, flag red flags worth urgent attention, and arrive at your next appointment with clear questions and a focused next step.
Last reviewed for medical accuracy: 10/22/2026
Extended-release nifedipine (brand name Procardia XL) is a calcium channel blocker commonly prescribed to treat high blood pressure (hypertension) and certain types of chest pain (angina). Like all medications, Procardia can cause side effects. This guide outlines what you might experience, how to manage common reactions, and when to seek medical help.
Throughout this article, we focus on “procardia side effects” so you know what to expect and how to stay safe.
Procardia XL relaxes and widens blood vessels, making it easier for your heart to pump and lowering blood pressure. Because it uses an extended-release formula, nifedipine is released slowly over 24 hours, helping maintain steady blood levels and consistent symptom control.
Common uses include:
Most people tolerate Procardia XL well, but you may notice mild to moderate side effects, especially when starting or adjusting dosage. These often improve over time as your body adapts.
Typical side effects include:
Tips for managing common side effects:
While most side effects are mild, Procardia XL can occasionally lead to more serious reactions. Contact your healthcare provider immediately if you experience any of the following:
Serious side effects:
Rare but important:
If you’re ever uncertain whether your symptoms are related to “procardia side effects” or something else, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker (https://ubiehealth.com/).
Timeline of side effects:
If side effects persist beyond a few weeks or significantly impact your daily life, speak to your doctor. They may adjust your dose or recommend an alternative medication.
Procardia XL can interact with other medications, herbs, or supplements. Always inform your doctor or pharmacist if you’re taking:
Special populations:
While most “procardia side effects” are manageable, some signs require immediate care. Call emergency services or go to your nearest ER if you experience:
For other concerning symptoms, don’t hesitate to speak with your healthcare provider. You can also perform a free, online symptom check, using the doctor approved Ubie Symptom Checker (https://ubiehealth.com/) to help decide your next steps.
Always keep an open dialogue with your healthcare team. Before starting Procardia XL, let them know about:
At follow-up visits, discuss:
Procardia XL (extended-release nifedipine) is an effective option for controlling high blood pressure and angina. While “procardia side effects” such as headache, flushing, or ankle swelling are common, they often improve with time and simple lifestyle measures. Stay vigilant for more serious reactions like chest pain changes, severe dizziness, or signs of liver trouble.
If you’re ever unsure, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker (https://ubiehealth.com/). And remember: always speak to a doctor about any symptoms that feel life-threatening or serious. Managing side effects, regular monitoring, and open communication with your healthcare provider will help you get the full benefit of Procardia XL while minimizing risks.
(References)
* Pérez C, Dougnac A, Alvarez M, Andresen M, Díaz O, Geni R, Prat G, Vásquez M. [Sublingual captopril versus nifedipine in the treatment of hypertensive crisis]. Rev Med Chil. 1991 Apr;119(4):402-5. PMID: 1842983.
* Tiegs G, Wolter M, Wendel A. Tumor necrosis factor is a terminal mediator in galactosamine/endotoxin-induced hepatitis in mice. Biochem Pharmacol. 1989 Feb 15;38(4):627-31. doi: 10.1016/0006-2952(89)90208-6. PMID: 2465008.
* Ene MD, Roberts CJ. Pharmacokinetics of nifedipine after oral administration in chronic liver disease. J Clin Pharmacol. 1987 Dec;27(12):1001-4. doi: 10.1002/j.1552-4604.1987.tb05604.x. PMID: 3437063.
* Tishler M, Armon S. Nifedipine-induced hypokalemia. Drug Intell Clin Pharm. 1986 May;20(5):370-1. doi: 10.1177/106002808602000507. PMID: 3709348.
* Welch HG, Lazar B, Gresser J, McMahon BJ. Nifedipine--induced hepatitis. Alaska Med. 1986 Jan-Mar;28(1):11-2. PMID: 3717520.
* Duriez J, Flautre B, Blary MC, Hardouin P. Effects of the calcium channel blocker nifedipine on epiphyseal growth plate and bone turnover: a study in rabbit. Calcif Tissue Int. 1993 Feb;52(2):120-4. doi: 10.1007/BF00308320. PMID: 8443687.
* Boelsterli UA, Ho HK, Zhou S, Leow KY. Bioactivation and hepatotoxicity of nitroaromatic drugs. Curr Drug Metab. 2006 Oct;7(7):715-27. doi: 10.2174/138920006778520606. PMID: 17073576.
* Patil K, Tabibian JH, Lake M, Sisson S. Nifedipine XL-induced dysuria. Am J Med. 2012 Sep;125(9):e3-4. doi: 10.1016/j.amjmed.2011.12.001. Epub 2012 Jun 9. PMID: 22682792.
* Lee SG, Kim J, Oh MS, Ryu B, Kang KR, Baek J, Lee JM, Choi SO, Kim CY, Chung HM. Development and validation of dual-cardiotoxicity evaluation method based on analysis of field potential and contractile force of human iPSC-derived cardiomyocytes / multielectrode assay platform. Biochem Biophys Res Commun. 2021 May 28;555:67-73. doi: 10.1016/j.bbrc.2021.03.039. Epub 2021 Apr 1. PMID: 33813278.
* Liang L, Kung JY, Mitchelmore B, Cave A, Banh HL. Comparative peripheral edema for dihydropyridines calcium channel blockers treatment: A systematic review and network meta-analysis. J Clin Hypertens (Greenwich). 2022 May;24(5):536-554. doi: 10.1111/jch.14436. Epub 2022 Mar 2. PMID: 35234349; PMCID: PMC9106091.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.